SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-287233
Filing Date
2015-08-12
Accepted
2015-08-12 07:01:17
Documents
9
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d58449d10q.htm 10-Q 251358
2 EX-31.1 d58449dex311.htm EX-31.1 5778
3 EX-32.1 d58449dex321.htm EX-32.1 2999
  Complete submission text file 0001193125-15-287233.txt   2079202

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rxii-20150630.xml EX-101.INS 305376
5 XBRL TAXONOMY EXTENSION SCHEMA rxii-20150630.xsd EX-101.SCH 21664
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20150630_cal.xml EX-101.CAL 36266
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20150630_def.xml EX-101.DEF 106465
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20150630_lab.xml EX-101.LAB 229701
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20150630_pre.xml EX-101.PRE 175197
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36304 | Film No.: 151045523
SIC: 2834 Pharmaceutical Preparations